IBEX Technologies, Inc.
IBEX Technologies, Inc. manufactures and markets a series of proprietary enzymes, which are used in pharmaceutical research, quality assurance and, in the case of Heparinase I, in diagnostic devices, which measure hemostasis in patients. It also develops, manufactures and markets arthritis assays, which are widely used in pharmaceutical research. The company's assays enable the measurement of cartilage synthesis and degradation, and powerful tools in the study of Osteoarthritis and rheumatoid arthritis. IBEX Technologies was founded on April 10, 1972 and is headquartered in Montréal, Canada.